1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Hua, Q.X. Liu, M. Hu, S.Q. Jia, W. Arvan, P. Weiss, M.A. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 281 24889 24899 10.1074/jbc.M602617200 16728398 A Conserved Histidine in Insulin Is Required for the Foldability of Human Proinsulin: Structure and function of an Alab5 analog. 2006 10.2210/pdb2h67/pdb pdb_00002h67 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 2383.698 Insulin A chain 1 man polymer 3343.825 Insulin B chain H29A,H34D,P52K, K53P 1 man polymer no no GIVEQCCTSICSLYQLENYCN GIVEQCCTSICSLYQLENYCN A polypeptide(L) no no FVNQALCGSDLVEALYLVCGERGFFYTKPT FVNQALCGSDLVEALYLVCGERGFFYTKPT B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia sample INS 9606 Homo sapiens 562 Escherichia coli human Homo Escherichia sample INS 9606 Homo sapiens 562 Escherichia coli database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2006-07-18 1 1 2008-05-01 1 2 2011-07-13 1 3 2021-10-20 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _struct_ref_seq_dif.details RCSB Y RCSB 2006-05-30 REL REL THIS STRUCTURE WAS DETERMINED USING STANDARD 2D HOMONUCLEAR NMR TECHNIQUES. structures with the lowest energy 40 20 2D TOCSY NOESY COSY 7.0 298 K 8.0 305 K 20% acetic acid 2.0 298 K RMSD VALUES FOR ALL 20 STRUCTURES VERSUS GEOMETRIC AVERAGE: (BACKBONE, A2-A20, B4-B24) 0.49 ANGSTROM DISTANCE GEOMETRY AND SIMULATED ANNEALING 1 lowest energy BRUNGER refinement X-PLOR 3.85 BRUNGER refinement CNS 1.1 Bruker processing XwinNMR 3.5 700 Bruker DRX GLY 1 n 1 GLY 1 A ILE 2 n 2 ILE 2 A VAL 3 n 3 VAL 3 A GLU 4 n 4 GLU 4 A GLN 5 n 5 GLN 5 A CYS 6 n 6 CYS 6 A CYS 7 n 7 CYS 7 A THR 8 n 8 THR 8 A SER 9 n 9 SER 9 A ILE 10 n 10 ILE 10 A CYS 11 n 11 CYS 11 A SER 12 n 12 SER 12 A LEU 13 n 13 LEU 13 A TYR 14 n 14 TYR 14 A GLN 15 n 15 GLN 15 A LEU 16 n 16 LEU 16 A GLU 17 n 17 GLU 17 A ASN 18 n 18 ASN 18 A TYR 19 n 19 TYR 19 A CYS 20 n 20 CYS 20 A ASN 21 n 21 ASN 21 A PHE 1 n 1 PHE 1 B VAL 2 n 2 VAL 2 B ASN 3 n 3 ASN 3 B GLN 4 n 4 GLN 4 B ALA 5 n 5 ALA 5 B LEU 6 n 6 LEU 6 B CYS 7 n 7 CYS 7 B GLY 8 n 8 GLY 8 B SER 9 n 9 SER 9 B ASP 10 n 10 ASP 10 B LEU 11 n 11 LEU 11 B VAL 12 n 12 VAL 12 B GLU 13 n 13 GLU 13 B ALA 14 n 14 ALA 14 B LEU 15 n 15 LEU 15 B TYR 16 n 16 TYR 16 B LEU 17 n 17 LEU 17 B VAL 18 n 18 VAL 18 B CYS 19 n 19 CYS 19 B GLY 20 n 20 GLY 20 B GLU 21 n 21 GLU 21 B ARG 22 n 22 ARG 22 B GLY 23 n 23 GLY 23 B PHE 24 n 24 PHE 24 B PHE 25 n 25 PHE 25 B TYR 26 n 26 TYR 26 B THR 27 n 27 THR 27 B LYS 28 n 28 LYS 28 B PRO 29 n 29 PRO 29 B THR 30 n 30 THR 30 B author_defined_assembly 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 1 B B O H VAL TYR 12 16 1.43 1 B B O H SER GLU 9 13 1.44 1 A A O H VAL CYS 3 7 1.45 2 B B O H VAL TYR 12 16 1.46 2 A A O HG1 GLU THR 4 8 1.46 2 A A O H VAL CYS 3 7 1.46 2 B B O H SER GLU 9 13 1.53 2 B B O H LEU LEU 11 15 1.55 3 B B O H LEU LEU 11 15 1.45 3 B B O H LEU VAL 15 18 1.45 4 B B O H LEU LEU 11 15 1.58 5 B B O H VAL TYR 12 16 1.38 5 B B O H SER GLU 9 13 1.50 5 B B O H LEU CYS 15 19 1.51 5 A B H O ASN GLY 21 23 1.59 7 B B O H VAL TYR 12 16 1.40 7 A A O H VAL CYS 3 7 1.50 7 B B O H SER GLU 9 13 1.53 9 B B O H VAL TYR 12 16 1.36 9 B B O H SER GLU 9 13 1.53 10 B B O H VAL TYR 12 16 1.40 10 B B O H LEU LEU 11 15 1.48 10 B B O H SER GLU 9 13 1.49 10 A A O H ILE GLN 2 5 1.53 10 B B O H LEU CYS 15 19 1.57 11 B B O H VAL TYR 12 16 1.46 11 B B O H SER GLU 9 13 1.47 11 B B O H LEU LEU 11 15 1.57 12 A A O H SER GLN 12 15 1.60 13 A A O H VAL CYS 3 7 1.55 13 B B O H LEU LEU 11 15 1.60 14 B B O H SER GLU 9 13 1.49 14 B B O H LEU LEU 11 15 1.53 14 A A O H VAL CYS 3 7 1.55 16 A A O H VAL CYS 3 7 1.55 17 A A O H SER GLN 12 15 1.60 18 A A O H VAL CYS 3 7 1.55 18 B B O H LEU LEU 11 15 1.60 19 A A O H VAL CYS 3 7 1.57 20 B B O H CYS ARG 19 22 1.52 20 B B O H LEU LEU 11 15 1.54 20 B B O H VAL TYR 12 16 1.57 1 B ARG 22 0.274 SIDE CHAIN 2 B ARG 22 0.245 SIDE CHAIN 3 B ARG 22 0.122 SIDE CHAIN 5 B ARG 22 0.315 SIDE CHAIN 7 B ARG 22 0.313 SIDE CHAIN 9 B ARG 22 0.213 SIDE CHAIN 10 B ARG 22 0.271 SIDE CHAIN 11 B ARG 22 0.286 SIDE CHAIN 13 B ARG 22 0.094 SIDE CHAIN 14 B ARG 22 0.302 SIDE CHAIN 18 B ARG 22 0.094 SIDE CHAIN 20 B ARG 22 0.317 SIDE CHAIN 3 -29.66 2.10 120.10 90.44 A A A CA C O ASN ASN ASN 21 21 21 N 14 -22.60 2.10 120.10 97.50 A A A CA C O ASN ASN ASN 21 21 21 N 20 -15.35 2.10 120.10 104.75 A A A CA C O ASN ASN ASN 21 21 21 N 14 A A C O ASN ASN 21 21 0.140 0.019 1.229 1.369 N 1 A GLU 4 -36.40 -34.86 1 A CYS 7 -78.16 -76.04 1 A THR 8 -55.86 -87.19 1 A SER 9 -49.37 173.46 1 A CYS 20 -49.89 178.89 1 B LEU 11 -66.69 -73.45 1 B CYS 19 -107.03 -73.25 1 B LYS 28 172.18 124.04 2 A THR 8 -61.89 -83.63 2 A SER 9 -57.67 -163.20 2 B LEU 11 -68.29 -70.82 3 A GLN 5 -100.32 -66.04 3 A SER 9 75.65 -140.76 3 B VAL 2 -127.03 -167.71 3 B ALA 5 -59.59 177.30 3 B TYR 16 -39.13 -31.63 3 B GLU 21 75.54 -8.03 3 B LYS 28 160.44 -49.19 4 A GLN 5 -63.27 -78.51 4 A SER 9 -177.82 -175.10 4 B VAL 2 -107.80 -159.63 4 B ASN 3 -93.27 43.36 4 B ALA 5 -72.81 -166.98 4 B LEU 6 -165.66 108.19 4 B LEU 11 -76.06 -70.60 4 B GLU 21 77.96 -0.95 4 B PHE 25 -98.25 -82.16 4 B TYR 26 38.44 75.36 4 B PRO 29 -59.59 170.91 5 B ALA 5 -68.17 -164.70 5 B LEU 6 -160.18 105.99 6 A ILE 2 -39.77 -33.17 6 A VAL 3 -90.74 -75.29 6 A GLU 4 -39.52 -30.89 6 A GLN 5 -88.79 -71.37 6 A THR 8 -84.43 -85.13 6 A CYS 11 -41.19 163.23 6 A CYS 20 -55.40 109.99 6 B VAL 2 -154.79 -154.13 6 B ALA 5 -134.49 -53.85 6 B LEU 6 65.09 87.43 6 B PHE 24 -54.37 177.31 6 B PHE 25 -101.46 -84.12 6 B TYR 26 35.01 72.23 6 B LYS 28 -148.98 50.54 7 A GLU 4 -38.77 -31.09 7 A GLN 5 -68.91 -78.56 7 A SER 9 69.54 -177.38 7 A CYS 20 -48.74 153.79 7 B ALA 5 -64.36 -176.94 7 B LEU 11 -51.82 -71.94 7 B CYS 19 -106.52 -77.32 7 B PHE 24 -160.81 -158.60 7 B PHE 25 173.46 83.22 7 B TYR 26 -72.91 -76.39 7 B LYS 28 179.14 138.23 8 A THR 8 -21.77 -56.47 8 B ASN 3 -103.32 53.65 8 B ALA 5 -59.11 -165.05 8 B LEU 6 -134.11 -56.74 8 B CYS 7 -31.24 148.50 8 B LEU 11 -80.77 -77.02 8 B CYS 19 -91.93 -65.01 8 B TYR 26 -62.66 88.99 8 B PRO 29 -66.72 20.64 9 A SER 9 58.67 -163.06 9 B LEU 11 -71.65 -70.37 9 B GLU 21 78.31 -5.50 10 A VAL 3 -23.65 -47.71 10 A GLU 4 -38.80 -27.89 10 A GLN 5 -105.98 -60.64 10 A SER 9 58.12 -167.35 10 B VAL 2 -157.47 -151.41 10 B ASN 3 82.32 31.77 10 B LEU 11 -67.45 -74.22 10 B CYS 19 -106.25 -78.27 10 B LYS 28 163.46 -47.31 11 A THR 8 -61.45 -131.50 11 A SER 9 -45.02 -99.86 11 B VAL 2 -79.33 -150.80 11 B ALA 5 -173.88 127.98 11 B LEU 6 -113.67 75.93 11 B CYS 19 -103.67 -75.57 11 B LYS 28 66.64 82.24 12 A SER 9 61.84 -160.41 12 B GLN 4 -75.94 -163.35 12 B ALA 5 -138.35 -46.87 12 B LEU 6 72.72 77.57 12 B LEU 11 -74.41 -70.24 12 B LEU 15 -90.24 -62.37 12 B GLU 21 83.70 -16.88 12 B PHE 24 46.73 172.52 12 B PHE 25 -119.58 -81.36 12 B TYR 26 42.41 81.53 12 B LYS 28 -52.51 177.44 13 A ILE 2 179.10 -46.09 13 A SER 9 -118.86 -166.25 13 B ASN 3 -94.39 41.44 13 B LEU 15 -77.65 -72.79 13 B ARG 22 -9.34 -73.30 13 B PHE 24 35.22 -163.31 13 B TYR 26 -68.68 69.80 13 B LYS 28 -134.37 -57.05 14 A SER 9 -133.06 -141.74 14 B VAL 2 -120.20 -166.52 14 B PHE 25 -143.56 43.67 14 B LYS 28 63.46 106.49 14 B PRO 29 -76.94 -169.68 15 A ILE 2 33.12 77.24 15 A GLU 4 -38.98 -33.06 15 A GLN 5 -91.31 -70.88 15 A CYS 7 -63.95 77.33 15 A THR 8 -177.32 -48.28 15 A CYS 20 -38.42 107.03 15 B ASN 3 -90.82 51.62 15 B GLN 4 -73.54 -153.31 15 B ALA 5 -154.67 -46.86 15 B LEU 6 83.28 82.98 15 B LEU 11 -68.93 -75.74 15 B LEU 15 -90.09 -64.97 15 B ARG 22 -108.09 69.36 15 B PHE 24 -55.28 -178.34 15 B PHE 25 -131.55 -84.79 15 B TYR 26 68.59 -29.08 16 A ILE 2 18.11 57.39 16 A GLN 5 -91.42 -61.01 16 A SER 9 -135.24 -158.85 16 A ILE 10 -105.22 78.17 16 B VAL 2 -133.48 -158.84 16 B ASN 3 -85.59 49.89 16 B GLN 4 -70.83 -139.28 16 B ALA 5 -160.69 -47.53 16 B LEU 6 81.91 83.51 16 B LEU 11 -63.39 -76.26 16 B LEU 15 -90.21 -63.41 16 B PHE 24 49.53 -172.07 16 B PHE 25 -114.59 -83.78 16 B TYR 26 44.03 84.62 16 B LYS 28 -179.87 -49.81 17 A SER 9 61.79 -160.44 17 B GLN 4 -75.98 -163.42 17 B ALA 5 -138.31 -46.86 17 B LEU 6 72.74 77.59 17 B LEU 11 -74.37 -70.36 17 B LEU 15 -90.19 -62.34 17 B GLU 21 83.76 -16.91 17 B PHE 24 46.83 172.52 17 B PHE 25 -119.64 -81.33 17 B TYR 26 42.47 81.49 17 B LYS 28 -52.50 177.43 18 A ILE 2 179.11 -46.13 18 A SER 9 -118.85 -166.26 18 B ASN 3 -94.39 41.46 18 B LEU 15 -77.65 -72.79 18 B ARG 22 -9.31 -73.30 18 B PHE 24 35.15 -163.30 18 B TYR 26 -68.63 69.81 18 B LYS 28 -134.29 -57.06 19 A VAL 3 -46.35 -70.62 19 B GLN 4 -76.22 -162.14 19 B ALA 5 -148.94 -49.12 19 B LEU 6 73.40 75.24 19 B LEU 11 -69.45 -73.60 19 B PHE 25 -106.70 -75.01 19 B TYR 26 55.90 109.01 19 B PRO 29 -65.56 10.37 20 A THR 8 -37.95 -95.30 20 A SER 9 -88.03 -108.21 20 A CYS 11 -54.28 -162.20 20 B GLN 4 35.81 -157.94 20 B ALA 5 87.42 109.14 20 B PHE 25 -144.45 28.93 20 B LYS 28 158.06 132.07 NMR structure of human insulin mutant HIS-B5-ALA, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structures 1 N N 2 N N A GLY 1 A GLY 1 HELX_P A CYS 7 A CYS 7 1 1 7 A SER 12 A SER 12 HELX_P A GLU 17 A GLU 17 1 2 6 B CYS 7 B CYS 7 HELX_P B CYS 19 B CYS 19 1 3 13 disulf 2.017 A CYS 6 A SG CYS 6 1_555 A CYS 11 A SG CYS 11 1_555 disulf 2.018 A CYS 7 A SG CYS 7 1_555 B CYS 7 B SG CYS 7 1_555 disulf 2.016 A CYS 20 A SG CYS 20 1_555 B CYS 19 B SG CYS 19 1_555 HORMONE/GROWTH FACTOR HORMONE, HUMAN INSULIN, MUTANT, HORMONE-GROWTH FACTOR COMPLEX INS_HUMAN UNP 1 90 P01308 GIVEQCCTSICSLYQLENYCN INS_HUMAN UNP 2 25 P01308 FVNQHLCGSHLVEALYLVCGERGFFYTPKT 90 110 2H67 1 21 P01308 A 1 1 21 25 54 2H67 1 30 P01308 B 2 1 30 2 HIS engineered mutation ALA 5 2H67 B P01308 UNP 29 5 2 HIS engineered mutation ASP 10 2H67 B P01308 UNP 34 10 2 PRO engineered mutation LYS 28 2H67 B P01308 UNP 52 28 2 LYS engineered mutation PRO 29 2H67 B P01308 UNP 53 29